seed
Stage
1
Investors
About
QTAS develops quantum sensing technologies for liquid biopsies to improve the detection and characterization of biomarkers, enabling sensitive downstream analyses such as single-cell sequencing and molecular profiling for neuro-oncological applications.
Explore QTAS's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.